DANOS LABORATORY
ActiveSummary
The annual accounts of DANOS LABORATORY for financial year 2025 show a net loss of 51% of the equity at the start of that year. The 2025 annual accounts show equity of €112,964 and a net result of -€115,433. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 31% of 20,620 sector peers (NACE 86, financial year 2025). The company has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
05-01
Gazette deed
Resignations: Omar DANDAN, Walid DANDAN and 2 othersDirector discharge10 facts ▸
- General meeting, 16-12-2025
- Director resignation, Omar DANDAN (director)
- Director discharge, Omar DANDAN
- Director resignation, Walid DANDAN (director)
- Director discharge, Walid DANDAN
- Director resignation, Hiba DANDAN (director)
- Director discharge, Hiba DANDAN
- Director resignation, Samia EL TAYARA (director)
- Director discharge, Samia EL TAYARA
- Other provision, “administrateur, gratuité du mandat d'administrateur” (deed in French)
Show earlier events
About the unread acts
Of the 6 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.